Inventor · disambiguated record
Alex Mueller
Also filed as: MUELLER ALEX
7 granted patents·4 pending applications·7 citations·filing 2006–2022
76Inventor score
Files withENDOGENA THERAPEUTICS INC8HOFFBAUER MARK1LOS ALAMOS NAT SECRUITY LLC1VALEO SIEMENS EAUTOMOTIVE GERMANY GMBH1
Top patents by PatentIndex Score
11 records- 0189US11844755B2Compounds and their use as therapeutically active substances in the treatment and/or reducing signs or symptoms of diseases involving the retinal pigment epitheliumENDOGENA THERAPEUTICS INC·Filed 2022·Granted Dec 19, 2023·1 cites·12 claims
- 0282US11541039B2Compounds and their use as therapeutically active substances in the treatment and/or reducing signs or symptoms of diseases involving the retinal pigment epitheliumENDOGENA THERAPEUTICS INC·Filed 2020·Granted Jan 3, 2023·1 cites·24 claims
- 0373US10807973B2Compounds for use as therapeutically active substances in the treatment of retinal diseasesENDOGENA THERAPEUTICS INC·Filed 2018·Granted Oct 20, 2020·1 cites·40 claims
- 0471US10752593B2Compounds for use as therapeutically active substances in the treatment of retinal diseasesENDOGENA THERAPEUTICS INC·Filed 2018·Granted Aug 25, 2020·1 cites·38 claims
- 0563US7393762B2Charge-free low-temperature method of forming thin film-based nanoscale materials and structures on a substrateLOS ALAMOS NAT SECRUITY LLC·Filed 2006·Granted Jul 1, 2008·3 cites·27 claims
- 0662US12195452B2N-(4-(oxazol-5-yl)phenyl) chromane-3-carboxamide derivatives and related compounds as stimulators of the production of retinal precursor cells for the treatment of neuroretinal diseasesENDOGENA THERAPEUTICS INC·Filed 2019·Granted Jan 14, 2025·0 cites·19 claims
- 0754US2023365545A1New compounds and their use as therapeutically active substances in the treatment and/or prevention of diseases involving the retinal pigment epitheliumENDOGENA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0849US2023322749A1New compounds and their use as therapeutically active substances in the treatment and/or prevention of diseases involving the retinal pigment epitheliumENDOGENA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0945US2009068821A1Charge-free low-temperature method of forming thin film-based nanoscale materials and structures on a substrateHOFFBAUER MARK·Filed 2008·Application pending·0 cites
- 1044US11617271B2Circuit arrangement, in particular for an electrically driven motor vehicleVALEO SIEMENS EAUTOMOTIVE GERMANY GMBH·Filed 2017·Granted Mar 28, 2023·0 cites·6 claims
- 1143US2022089547A1Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseasesENDOGENA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alex Mueller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →